Searched for
API LICENCE
Bengaluru property: My e-Khata My Hakku camps to open from May 16 at these locations; Convert B-Khata to A-Khata hereBengaluru property owners can now convert their B-Khata to A-Khata through government-organized camps starting May 16th. Under the 'Bhoo Gu...- India must leverage its digital verification architecture to evolve into a trust-based economyIndia faces a low-trust economy with high friction, exemplified by complex KYC norms. Finance Minister Nirmala Sitharaman highlighted this ...
- Cohance Lifesciences shares skyrocket 20% on hiring former Cipla CEO Umang VohraShares of Cohance Lifesciences surged 20% on Monday after the appointment of former Cipla CEO Umang Vohra as its new Executive Chairman and...
- Cashfree Payments appoints former Visa executive Sameer Gandhi as CFOCashfree Payments has appointed Sameer Gandhi as its new Chief Financial Officer, bringing over two decades of experience from global finan...
- Quick access to key HIV drug hinges on waiver of local clinical trials: ExpertsFaster access to HIV drug lenacapavir in India hinges on the waiver of local clinical trials. Six companies, including three from India, ha...
- Setu gets in-principle RBI nod for account aggregator licencePine Labs acquired Setu in a cash-and-stock deal worth $70-75 million last month.
- Govt frees OLED, liquid crystals imports, Remdesivir exportsIn a separate notification, the Directorate General of Foreign Trade also said that Remdesivir Injection and API, Amphotericin-B Injections...
- Government puts curbs on export of Enoxaparin"The export of Enoxaparin (formulation and API) and intra-venous immunoglobulin (formulation and API) ....has been put under restricted cat...
- CSIR-IICT, Bengaluru pharma firm join hands to manufacture anti-COVID drug 2-DGThe CSIR-Indian Institute of Chemical Technology (IICT) here and Bengaluru-based Anthem Biosciences Pvt Ltd have entered into an agreement ...
- Govt allows Remdesivir exports under licence“The export of injection Remdesivir and its API… have been put under Restricted category with immediate effect. The export of Remdesivir In...
- India may allow Remdesivir exporters to sell drug in domestic marketThe measure is expected to boost availability of the drug that’s being used for Covid treatment. Supplies of the drug have been running low...
- Remdesivir exporters in a spot after shipments banAny duty-free import allowed under advance licence has to be matched with exports, but exporters manufacturing remdesivir have been barred ...
- Govt lifts curbs on exports of formulations made from ParacetamolThe government on March 3 had put export restrictions on 26 pharma ingredients and medicines, including paracetamol. However on April 6, it...
- Covid-19: Export curbs on imported API drugs under reviewThe commerce and industry ministry is studying a proposal to allow exports of drugs from active pharmaceutical ingredients (API) which have...
- Exporters line up for restricted Active Pharmaceutical Ingredients licenceThe government, on March 3, restricted the exports of 26 API and formulations, including paracetamol and vitamins B1, B6 and B12 in order t...
- AstraZeneca Pharma India to close Bengaluru API unitDrug firm AstraZeneca Pharma India will close its Active Pharmaceutical Ingredient (API) unit at Bengaluru due to low demand for the produc...
- Dishman gets licence from Johnson & Johnson to produce TB drug raw materialDishman Pharmaceuticals and Chemicals today said it has received a licence from Johnson & Johnson to manufacture raw material for a tubercu...
- Dishman Pharma hits 52-week high as drug maker gets licence to manufacture TB medicineDishman Pharmaceuticals and Chemicals surged 16.22 per cent to close at 306.95. The stock closed at a fresh 52-week high on Wednesday.
- Licences of six developers cancelled in LucknowThe Lucknow Development Authority has decided to cancel the licenses of major private builders, engaged in developing integrated townships ...
- Ranbaxy in pact with Gilead for 'Tenofovir'Ranbaxy Laboratories Ltd said on Monday that it has entered into a licensing agreement with US-based Gilead Sciences Inc for manufacturing ...
Load More
